RATIONALE: The medial prefrontal cortex (mPFC) is a key neural region involved in opiate-related reward memory processing. AMPA receptor transmission in the mPFC modulates opiate-related reward memory processing, and chronic opiate exposure is associated with alterations in intra-mPFC AMPA receptor function. OBJECTIVE: The objectives of this study were to examine how pharmacological blockade of AMPA receptor transmission in the prelimbic (PLC) division of the mPFC may modulate opiate reward memory acquisition and whether opiate exposure state may modulate the functional role of intra-PLC AMPA receptor transmission during opiate reward learning. METHODS: Using an unbiased conditioned place preference (CPP) procedure in rats, we performed discrete, bilateral intra-PLC microinfusions of the AMPA receptor antagonist, 6,7-dinitroquinoxaline-2,3-dione, prior to behavioral morphine CPP conditioning, using sub-reward threshold conditioning doses of either systemic (0.05 mg/kg; i.p.) or intra-ventral tegmental area (VTA) morphine (250 ng/0.5 μl). RESULTS: We show that, in both opiate-naïve and opiate-dependent states, intra-PLC blockade of AMPA receptor transmission, but not the infralimbic cortex, increases the behavioral reward magnitude of systemic or intra-VTA morphine. This effect is dependent on dopamine (DA)ergic signaling because pre-administration of cis-(Z)-flupenthixol-dihydrochloride (α-flu), a broad-spectrum dopamine receptor antagonist, blocked the morphine-reward potentiating effects of AMPA receptor blockade. CONCLUSIONS: These findings suggest a critical role for intra-PLC AMPA receptor transmission in the processing of opiate reward signaling. Furthermore, blockade of AMPA transmission specifically within the PLC is capable of switching opiate reward processing to a DA-dependent reward system, independently of previous opiate exposure history.
RATIONALE: The medial prefrontal cortex (mPFC) is a key neural region involved in opiate-related reward memory processing. AMPA receptor transmission in the mPFC modulates opiate-related reward memory processing, and chronic opiate exposure is associated with alterations in intra-mPFC AMPA receptor function. OBJECTIVE: The objectives of this study were to examine how pharmacological blockade of AMPA receptor transmission in the prelimbic (PLC) division of the mPFC may modulate opiate reward memory acquisition and whether opiate exposure state may modulate the functional role of intra-PLC AMPA receptor transmission during opiate reward learning. METHODS: Using an unbiased conditioned place preference (CPP) procedure in rats, we performed discrete, bilateral intra-PLC microinfusions of the AMPA receptor antagonist, 6,7-dinitroquinoxaline-2,3-dione, prior to behavioral morphine CPP conditioning, using sub-reward threshold conditioning doses of either systemic (0.05 mg/kg; i.p.) or intra-ventral tegmental area (VTA) morphine (250 ng/0.5 μl). RESULTS: We show that, in both opiate-naïve and opiate-dependent states, intra-PLC blockade of AMPA receptor transmission, but not the infralimbic cortex, increases the behavioral reward magnitude of systemic or intra-VTA morphine. This effect is dependent on dopamine (DA)ergic signaling because pre-administration of cis-(Z)-flupenthixol-dihydrochloride (α-flu), a broad-spectrum dopamine receptor antagonist, blocked the morphine-reward potentiating effects of AMPA receptor blockade. CONCLUSIONS: These findings suggest a critical role for intra-PLC AMPA receptor transmission in the processing of opiate reward signaling. Furthermore, blockade of AMPA transmission specifically within the PLC is capable of switching opiate reward processing to a DA-dependent reward system, independently of previous opiate exposure history.
Authors: Daniel D Langleben; Kosha Ruparel; Igor Elman; Samantha Busch-Winokur; Ramapriyan Pratiwadi; James Loughead; Charles P O'Brien; Anna R Childress Journal: Am J Psychiatry Date: 2007-12-03 Impact factor: 18.112
Authors: Matthew T C Brown; Camilla Bellone; Manuel Mameli; Gwenael Labouèbe; Christina Bocklisch; Bénédicte Balland; Lionel Dahan; Rafael Luján; Karl Deisseroth; Christian Lüscher Journal: PLoS One Date: 2010-12-31 Impact factor: 3.240
Authors: Danika Lyons; Xavier de Jaeger; Laura G Rosen; Tasha Ahmad; Nicole M Lauzon; Jordan Zunder; Lique M Coolen; Walter Rushlow; Steven R Laviolette Journal: J Neurosci Date: 2013-09-11 Impact factor: 6.167
Authors: Laura G Rosen; Jordan Zunder; Justine Renard; Jennifer Fu; Walter Rushlow; Steven R Laviolette Journal: Neuropsychopharmacology Date: 2015-07-15 Impact factor: 7.853
Authors: Jing Jing Li; Hanna Szkudlarek; Justine Renard; Roger Hudson; Walter Rushlow; Steven R Laviolette Journal: J Neurosci Date: 2018-04-23 Impact factor: 6.167
Authors: Huibing Tan; Laura G Rosen; Garye A Ng; Walter J Rushlow; Steven R Laviolette Journal: Psychopharmacology (Berl) Date: 2014-05-29 Impact factor: 4.530
Authors: Huibing Tan; Tasha Ahmad; Michael Loureiro; Jordan Zunder; Steven R Laviolette Journal: Front Psychiatry Date: 2014-06-30 Impact factor: 4.157